Epilepsy, Idiopathic Generalized

1

Review clinical trials related to Epilepsy, Idiopathic Generalized. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Idiopathic Generalized Epilepsy Syndromes

The idiopathic generalized epilepsies (IGEs) have historically included the syndromes childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE), juvenile myoclonic epilepsy (JME), and epilepsy with generalized tonic-clonic seizures alone (GTCA). Recognition of the IGEs is important for clinical care, as it informs diagnosis, prevents unnecessary investigation, allows optimal selection of anti-seizure medications (ASMs), and provides prognostic guidance. According to the new ILAE definition in 2022, the study aims to describe the clinical features, electroencephalographic, imaging findings and long-term prognosis.

Participants needed: 200
Trial details
Age: 4-40Biological sex: AllType: ObservationalSponsor: Shen Chun-HongUpdated: Aug 27, 2025Locations: 1
Eligibility criteria

Patients are consecutively and prospectively enrolled from epilepsy center, with... [+3]

Other epilepsy syndromes are considered during follow-up, such as genetic genera... [+1]